145: ID/KLH active immunotherapy (FAVID®) following high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for non-hodgkin's lymphoma (NHL)

P.P. Holman, M. deMagalhaes-Silverman, S. Corringham, J.E. Castro, E. Carrier, T. Lane, D. Gold, E. Ball
2007 Biology of Blood and Marrow Transplantation  
prior to mobilization and progression free survival as well as overall survival. Conclusion: We conclude that 1) degree of plasma cell BM infiltration before mobilization did not predict for transplant outcomes and 2) increased plasma cell BM infiltration before mobilization adversely affect the efficiency of stem cell mobilization. Thus, pre-transplant cytoreductive therapy improves stem cell collection efficiency but did not affect the transplant outcomes.
doi:10.1016/j.bbmt.2006.12.149 fatcat:snujv2vchfbr3pqup733gqnxua